PHF5A调节DOCK5变异的表达,通过p38 MAPK激活促进HNSCC的进展
Chao Liu1,2,3, Guo Li1,2,3, Siyuan Zheng1,2,3
1Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, 410008, China.
结合体基因PHF5A通过调节DOCK5变体和激活p38 MAPK通路来促进头支状细胞癌 (HNSCC) 的进展. PHF5A为HNSCC提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 在头部和部状细胞癌 (HNSCC) 中确定了DOCK5的瘤拼接变异.
- 在HNSCC中产生这种DOCK5变异的机制以前是未知的.
研究的目的:
- 研究参与产生DOCK5变异的结合体基因.
- 验证DOCK5变异在HNSCC进展中的作用.
主要方法:
- 在TCGA HNSCC数据中分析了差异表达的结合体基因.
- 使用qRT-PCR验证了DOCK5变异和PHF5A之间的相关性.
- 在HNSCC细胞,TCGA数据和原发性瘤中评估PHF5A表达.
- 进行了体外和体内功能测试,以评估PHF5A的作用.
- 通过Western blot和p38 MAPK通路分析探索PHF5A的机制.
主要成果:
- 在HNSCC中,PHF5A上调,DOCK5变体表达高,与预后不佳相关.
- PHF5A调节了DOCK5变异水平,并促进了HNSCC细胞的增殖,迁移和入侵.
- PHF5A激活了p38 MAPK通路,有助于HNSCC的进展.
- 抑制PHF5A可以逆转DOCK5变异的致癌效应.
结论:
- PHF5A调节DOCK5的替代拼接,通过p38 MAPK激活促进HNSCC的进展.
- PHF5A代表了HNSCC治疗的潜在治疗标.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
03:37Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
相关概念视频
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Hedgehog Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
